Health care startups that raised Series A in Europe
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| OSSTEC | London | Series A | $8.0M | 2026-11-03 |
| Bioliberty | Edinburgh | Series A | $3.3M | 2026-11-02 |
| Adsilico | Leeds | Series A | $13.3M | 2026-10-26 |
| Cellbox Solutions | Cologne | Series A | $1.7M | 2026-10-20 |
| Archeon | Besançon | Series A | $9.0M | 2026-10-06 |
| Dyad | London | Series A | $10.0M | 2026-09-29 |
| Living Optics | Milton Keynes | Series A | $20.0M | 2026-09-24 |
| Dialybrid | Cantù | Series A | $17.2M | 2026-09-22 |
8 rows of the CSV in 5 of its 18 columns.
- The 885 health care startups in Europe whose last round is Series A have raised $10.0B in total.
- 97 of them closed their most recent round in the last 12 months, $2.2B combined.
- The largest of those rounds is Coultreon Biopharma's $125.0M Series A, dated April 2026.
- The most recent is Alethio Therapeutics' $90.0M Series A on 5 November 2026.
- HTGF (High-Tech Gruenderfonds) is an investor in 21 of them, more than any other fund.
- Biotech is the most common other sector, with 373 companies (42%).
- 19% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (56% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 885| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| OSSTEC | OSSTEC develops products for orthopaedic treatment. | Hardware | London, United Kingdom | Series A | $8.0M | 2026-11-03 | $12.7M | SFC Capital, Parkwalk Advisors, Embryo Ventures +1 | 11 to 50 | 2021 |
| Bioliberty | Bioliberty develops rehabilitation solutions for degenerative and traumatic conditions as a medtech start-up. | Biotech | Edinburgh, United Kingdom | Series A | $3.3M | 2026-11-02 | $17.4M | Innovate UK, Scottish Enterprise, Old College Capital +2 | 11 to 50 | 2020 |
| Adsilico | Adsilico develops new approaches to medical device innovation. | Health care | Leeds, United Kingdom | Series A | $13.3M | 2026-10-26 | $17.8M | Parkwalk Advisors, Northern Gritstone | 1 to 10 | 2022 |
| Cellbox Solutions | Cellbox Solutions provides logistics solutions for the global biomedical industry. | Biotech | Cologne, Germany | Series A | $1.7M | 2026-10-20 | $15.3M | European Innovation Council, Fraunhofer Venture, CK Venture Capital | 11 to 50 | 2017 |
| Archeon | Archeon develops solutions for monitoring, diagnosing, and treating critically ill patients. | Health care | Besançon, France | Series A | $9.0M | 2026-10-06 | $15.1M | Bpifrance, Daphni, Karot Capital +1 | 11 to 50 | 2018 |
| Dyad | Dyad builds trust in data and develops AI-powered tools for healthcare operations. | Artificial intelligence | London, United Kingdom | Series A | $10.0M | 2026-09-29 | $14.0M | Plug and Play, Pantera Capital, Carbide Ventures | 11 to 50 | 2020 |
| Living Optics | Living Optics develops imaging technology. | Artificial intelligence | Milton Keynes, United Kingdom | Series A | $20.0M | 2026-09-24 | $49.3M | Octopus Ventures, Oxford Science Enterprises, Outsized Ventures +2 | 11 to 50 | 2020 |
| Dialybrid | Dialybrid develops vascular grafts for hemodialysis made from silk fibroin and polyurethane. | Health care | Cantù, Italy | Series A | $17.2M | 2026-09-22 | $17.6M | LIFTT | 1 to 10 | 2020 |
| Biolevate | Biolevate provides an AI platform that helps life sciences teams run regulated operations with auditable workflows. | Artificial intelligence | Paris, France | Series A | $34.4M | 2026-09-21 | $40.7M | Bpifrance, EQT Ventures | 11 to 50 | 2024 |
| Matisse Pharmaceuticals | Matisse Pharmaceuticals develops therapies for sepsis and septic shock by targeting cytotoxic histones. | Biotech | Geleen, The Netherlands | Series A | $16.0M | 2026-09-17 | $22.0M | Brightlands Venture Partners, Chemelot Ventures, Limburg Business Development Fund (LBDF) | 11 to 50 | 2014 |
| Hope Care Health | Hope Care created OpMA, a regulated software device that unifies outpatient remote monitoring to support Hospital-at-Home. | Health care | Óbidos, Portugal | Series A | $7.0M | 2026-09-08 | $7.0M | GED Ventures Portugal | 11 to 50 | 2012 |
| Amyl Therapeutics | Amyl Therapeutics is a preclinical biotechnology company developing immunotherapy for neurodegenerative diseases. | Biotech | Liège, Belgium | Series A | $9.6M | 2026-09-01 | $44.0M | Meusinvest (Noshaq), Sambrinvest, Mérieux Equity Partners +1 | 1 to 10 | 2020 |
| Kynexis | Kynexis develops precision medicine treatments for cognitive impairment associated with schizophrenia. | Biotech | Naarden, The Netherlands | Series A | $112.3M | 2026-08-19 | $173.3M | Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures | 11 to 50 | 2023 |
| Unikum.net | Unikum.net operates a European PreK-12 cloud platform for schools and students. | Artificial intelligence | Stockholm, Sweden | Series A | $700K | 2026-08-18 | $2.7M | JCE Group, Tequity | 51 to 100 | 2005 |
| Alchemab Therapeutics | Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. | Biotech | London, United Kingdom | Series A | $33.6M | 2026-07-09 | $151.1M | DCVC, RA Capital Management, DHVC +2 | 51 to 100 | 2019 |
| SOMAREALITY | SOMAREALITY develops spatial computing and eye tracking technology to measure cognitive digital biomarkers. | Education | Vienna, Austria | Series A | $3.4M | 2026-06-18 | $8.4M | Startup Wise Guys, The Austrian Research Promotion Agency (FFG), Gateway Ventures +2 | 11 to 50 | 2019 |
| Apoha | Apoha is a start-up that has not yet publicly launched. | Biotech | London, United Kingdom | Series A | $36.0M | 2026-06-03 | $36.0M | Plug and Play, Innovate UK, Intel Ignite +2 | 1 to 10 | 2021 |
| mbiomics | mbiomics is a biotechnology company. | Biotech | Munich, Germany | Series A | $12.0M | 2026-04-28 | $26.1M | HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Capital | 11 to 50 | 2020 |
| Lucida Medical | Lucida Medical develops software for cancer diagnosis using MRI and radiology imaging, particularly for prostate cancer. | Biotech | Cambridge, United Kingdom | Series A | $11.5M | 2026-03-30 | $22.5M | Innovate UK, XTX Ventures, WDH Investments | 11 to 50 | 2019 |
| Rivia | Rivia provides an operating system that aims to improve clinical trial outcomes. | Artificial intelligence | Zürich, Switzerland | Series A | $15.0M | 2026-03-18 | $18.2M | Speedinvest, Nina Capital, Amino Collective | 1 to 10 | 2022 |
| RAYDIAX | RAYDIAX manufactures therapy-assist CT systems that enable minimally invasive interventions. | Hardware | Magdeburg, Germany | Series A | $5.9M | 2026-03-01 | $12.5M | HTGF (High-Tech Gruenderfonds), bmp Ventures, Federal Ministry for Economic Cooperation and Development | 11 to 50 | 2022 |
| nyra health | Nyra Health offers an AI and evidence-based neurological research tablet app for therapy. | Artificial intelligence | Vienna, Austria | Series A | $23.6M | 2026-02-24 | $28.5M | Wellington Partners, MassMutual Ventures, Hardlymountain | 11 to 50 | 2020 |
| MyC | MyC provides a workforce health platform that unifies employee health data and automates compliance. | Health care | Montreuil, France | Series A | $11.8M | 2026-02-03 | $14.2M | Elaia | 11 to 50 | 2009 |
| Biorce | Biorce develops a clinical AI assistant that speeds up and lowers the cost of clinical trials. | Artificial intelligence | Barcelona, Spain | Series A | $52.0M | 2026-02-02 | $61.5M | Plug and Play, YZR Capital, Outsized Ventures +1 | 11 to 50 | 2024 |
| Leman Biotech | Leman Biotech develops cancer immunotherapies as a biotech company. | Biotech | Lausanne, Switzerland | Series A | $28.8M | 2026-01-26 | $46.8M | Tiantu Capital, Fuho Capital | 11 to 50 | 2021 |
| Octarine Bio | Octarine Bio is a synthetic biology company that produces cannabinoids for the pharmaceutical industry. | Biotech | Copenhagen, Denmark | Series A | $5.9M | 2026-01-22 | $15.5M | MassChallenge, Vaekstfonden, Unconventional Ventures +2 | 11 to 50 | 2018 |
| Altavo | Altavo develops medical devices as a startup. | Health care | Dresden, Germany | Series A | $3.5M | 2026-01-22 | $8.9M | HTGF (High-Tech Gruenderfonds), TGFS - Technologiegründerfonds Sachsen, bm-t beteiligungsmanagement thuringen +2 | 11 to 50 | 2021 |
| Eolas Medical | Eolas Medical organizes medical information worldwide to make healthcare simpler, safer, and smarter. | Health care | Belfast, United Kingdom | Series A | $12.1M | 2026-01-20 | $12.1M | Ascension, 7percent Ventures | 11 to 50 | 2019 |
| Carol | Carol is a tech-enabled healthcare provider offering membership-based primary care services. | Health care | Milan, Italy | Series A | $7.6M | 2026-01-14 | $15.2M | P101, Exceptional Ventures, Alecla7 +2 | 11 to 50 | 2022 |
| Luminate Medical | Luminate Medical develops a medical device that prevents hair loss during chemotherapy. | Biotech | Galway, Ireland | Series A | $21.0M | 2026-01-07 | $60.6M | Y Combinator, Pareto Holdings, EIC Accelerator +1 | 11 to 50 | 2018 |
Table 1. Health care startups that raised Series A in Europe: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 885.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Kynexis | Kynexis develops precision medicine treatments for cognitive impairment associated with schizophrenia. | Biotech | Naarden, The Netherlands | Series A | $112.3M | 2026-08-19 | $173.3M | Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures | 11 to 50 | 2023 |
| 2 | Biorce | Biorce develops a clinical AI assistant that speeds up and lowers the cost of clinical trials. | Artificial intelligence | Barcelona, Spain | Series A | $52.0M | 2026-02-02 | $61.5M | Plug and Play, YZR Capital, Outsized Ventures +1 | 11 to 50 | 2024 |
| 3 | Apoha | Apoha is a start-up that has not yet publicly launched. | Biotech | London, United Kingdom | Series A | $36.0M | 2026-06-03 | $36.0M | Plug and Play, Innovate UK, Intel Ignite +2 | 1 to 10 | 2021 |
| 4 | Biolevate | Biolevate provides an AI platform that helps life sciences teams run regulated operations with auditable workflows. | Artificial intelligence | Paris, France | Series A | $34.4M | 2026-09-21 | $40.7M | Bpifrance, EQT Ventures | 11 to 50 | 2024 |
| 5 | Alchemab Therapeutics | Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. | Biotech | London, United Kingdom | Series A | $33.6M | 2026-07-09 | $151.1M | DCVC, RA Capital Management, DHVC +2 | 51 to 100 | 2019 |
| 6 | EpilepsyGTx | EpilepsyGTx develops gene therapies to improve management of focal refractory epilepsy in late-stage clinical development. | Biotech | Canterbury, United Kingdom | Series A | $33.0M | 2025-12-10 | $43.0M | UCL Technology Fund, HTH | 1 to 10 | 2021 |
| 7 | Leman Biotech | Leman Biotech develops cancer immunotherapies as a biotech company. | Biotech | Lausanne, Switzerland | Series A | $28.8M | 2026-01-26 | $46.8M | Tiantu Capital, Fuho Capital | 11 to 50 | 2021 |
| 8 | nyra health | Nyra Health offers an AI and evidence-based neurological research tablet app for therapy. | Artificial intelligence | Vienna, Austria | Series A | $23.6M | 2026-02-24 | $28.5M | Wellington Partners, MassMutual Ventures, Hardlymountain | 11 to 50 | 2020 |
| 9 | Luminate Medical | Luminate Medical develops a medical device that prevents hair loss during chemotherapy. | Biotech | Galway, Ireland | Series A | $21.0M | 2026-01-07 | $60.6M | Y Combinator, Pareto Holdings, EIC Accelerator +1 | 11 to 50 | 2018 |
| 10 | Living Optics | Living Optics develops imaging technology. | Artificial intelligence | Milton Keynes, United Kingdom | Series A | $20.0M | 2026-09-24 | $49.3M | Octopus Ventures, Oxford Science Enterprises, Outsized Ventures +2 | 11 to 50 | 2020 |
Table 2. Health care startups that raised Series A in Europe: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | 21 | 2% | 3 | mbiomics, RAYDIAX, Altavo |
| 2 | Bpifrance | Government investment office | Maisons-alfort, France | 12 | 1% | 2 | Archeon, Biolevate |
| 3 | Venture Kick | Startup incubator | Schlieren, Switzerland | 12 | 1% | ||
| 4 | European Innovation Council | Startup accelerator | Brussels, Belgium | 10 | 1% | 1 | Cellbox Solutions |
| 5 | Bayern Kapital | Venture capital firm | Landshut, Germany | 8 | 1% | 1 | mbiomics |
| 6 | Innovate UK | Entrepreneurship program | Swindon, United Kingdom | 7 | 1% | 3 | Bioliberty, Apoha, Lucida Medical |
| 7 | Plug and Play | Startup accelerator | Sunnyvale, United States | 7 | 1% | 3 | Dyad, Apoha, Biorce |
| 8 | Speedinvest | Venture capital firm | Vienna, Austria | 7 | 1% | 1 | Rivia |
| 9 | Sofinnova Partners | Venture capital firm | Paris, France | 7 | 1% | ||
| 10 | Parkwalk Advisors | Venture capital firm | London, United Kingdom | 6 | 1% | 2 | OSSTEC, Adsilico |
| 11 | Elaia | Venture capital firm | Paris, France | 6 | 1% | 2 | MyC, Sim&Cure |
| 12 | EIC Accelerator | Startup accelerator | Brussels, Belgium | 6 | 1% | 1 | Luminate Medical |
| 13 | EQT Ventures | Venture capital firm | Stockholm, Sweden | 5 | 1% | 1 | Biolevate |
| 14 | RA Capital Management | Startup incubator | Boston, United States | 5 | 1% | 1 | Alchemab Therapeutics |
| 15 | Foundation for Innovation and Technology (FIT) | Entrepreneurship program | Lausanne, Switzerland | 5 | 1% |
Table 3. Health care startups that raised Series A in Europe: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 373 | 42% | $6.6B |
| Software | 212 | 24% | $1.9B |
| Artificial intelligence | 88 | 10% | $1.2B |
| Hardware | 70 | 8% | $268.5M |
| Commerce | 34 | 4% | $51.4M |
| Fintech | 20 | 2% | $51.9M |
| Education | 18 | 2% | $98.9M |
| Energy | 5 | 1% | |
| Cybersecurity | 3 | 0% | $49.7M |
Table 4. Health care startups that raised Series A in Europe by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 885 | 100% | $7.0M |
Table 5. Health care startups that raised Series A in Europe by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| United Kingdom | 214 | 24% |
| France | 132 | 15% |
| Germany | 129 | 15% |
| Switzerland | 89 | 10% |
| The Netherlands | 47 | 5% |
| Spain | 44 | 5% |
| Belgium | 35 | 4% |
| Italy | 30 | 3% |
| Denmark | 27 | 3% |
| Sweden | 23 | 3% |
| Austria | 21 | 2% |
| Ireland | 19 | 2% |
Table 6. Health care startups that raised Series A in Europe by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Health care startups that raised Series A in Europe by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 4 | 4% | $146.2M |
| October 2026 | 10 | 10% | $141.1M |
| September 2026 | 15 | 15% | $340.1M |
| August 2026 | 4 | 4% | $136.2M |
| July 2026 | 6 | 6% | $82.1M |
| June 2026 | 11 | 11% | $334.3M |
| May 2026 | 3 | 3% | $126.0M |
| April 2026 | 4 | 4% | $146.8M |
| March 2026 | 8 | 8% | $92.2M |
| February 2026 | 7 | 7% | $164.5M |
| January 2026 | 10 | 10% | $149.5M |
| December 2025 | 11 | 11% | $284.1M |
| November 2025 | 4 | 4% | $57.8M |
Table 8. Health care startups that raised Series A in Europe: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 82 | 9% | $1.9B |
| 2025 | 88 | 10% | $2.1B |
| 2024 | 90 | 10% | $1.5B |
| 2023 | 83 | 9% | $1.2B |
| 2022 | 94 | 11% | $1.1B |
| 2021 | 86 | 10% | $1.0B |
Table 9. Health care startups that raised Series A in Europe by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 35 | 4% |
| 2020 to 2022 | 133 | 15% |
| 2015 to 2019 | 382 | 43% |
| 2010 to 2014 | 220 | 25% |
| Before 2010 | 110 | 12% |
Table 10. Health care startups that raised Series A in Europe by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 246 | 28% |
| 11 to 50 | 493 | 56% |
| 51 to 100 | 92 | 11% |
| 101 to 250 | 27 | 3% |
| 251 to 500 | 8 | 1% |
| 501 to 1,000 | 3 | 0% |
| 1,001 to 5,000 | 3 | 0% |
| 10,001 or more | 1 | 0% |
Table 11. Health care startups that raised Series A in Europe by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series A and its headquarters is in Europe. On 16 November 2026 that is 885 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 885 rows: 142 have no round amount, 0 no city and 276 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Europe whose last round is Series A are on the list?
- 885, in the file dated 16 November 2026. 97 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 885 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.